PHASE-II EVALUATION OF THE SULFONYLUREA LY186,641 IN MEN WITH HORMONE-INDEPENDENT METASTATIC PROSTATE-CANCER

被引：1
|
作者：
WILDING, G
GRINDEY, G
MUNSHI, N
SEITZ, D
EINHORN, L
机构：
[1] WM S MIDDLETON VA HOSP,MADISON,WI
[2] ELI LILLY CORP,LILLY RES LABS,INDIANAPOLIS,IN
[3] INDIANA UNIV,MED CTR,DEPT MED,DIV HEMATOL ONCOL,INDIANAPOLIS,IN 46204
来源：
INVESTIGATIONAL NEW DRUGS | 1993年 / 11卷 / 2-3期
关键词：
D O I：
10.1007/BF00874156
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
[No abstract available]
引用
收藏
页码：203 / 205
页数：3
相关论文
共 50 条
  • [31] PHASE-II EVALUATION OF BISANTRENE IN METASTATIC BREAST-CANCER
    CAVALLI, F
    GERARD, B
    HUININK, WT
    CLAVEL, M
    ROZENCWEIG, M
    CANCER TREATMENT REPORTS, 1985, 69 (03): : 337 - 338
  • [32] EUROPEAN ORGANIZATION FOR RESEARCH AND TREATMENT OF CANCER (EORTC) PHASE-II STUDY OF LOW-DOSE WEEKLY EPIRUBICIN IN METASTATIC PROSTATE-CANCER
    JONES, WG
    FOSSA, SD
    BONO, AV
    KLIJN, JGM
    DEPAUW, M
    SYLVESTER, R
    CANCER TREATMENT REPORTS, 1987, 71 (12): : 1317 - 1318
  • [33] PHASE-II TRIAL OF A NEW BIOLOGICAL RESPONSE MODIFIER (IMUVERT) IN ADVANCED PROSTATE-CANCER
    OSBORNE, CK
    CRAIG, JB
    KLEIN, K
    CRAWFORD, ED
    TURNER, J
    INVESTIGATIONAL NEW DRUGS, 1989, 7 (2-3) : 243 - 245
  • [34] PHASE-II TRIAL OF ETOPOSIDE (VP16-213) IN ADVANCED PROSTATE-CANCER
    LOPRINZI, CL
    TRUMP, DL
    CLINICAL RESEARCH, 1984, 32 (02): : A418 - A418
  • [35] PHASE-II TRIAL AND PHARMACOKINETIC ASSESSMENT OF INTRAVENOUS MELPHALAN IN PATIENTS WITH ADVANCED PROSTATE-CANCER
    SMITH, DC
    JODRELL, DI
    EGORIN, MJ
    AMBINDER, RM
    ZUHOWSKI, EG
    KREIS, W
    ELLIS, PG
    TRUMP, DL
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 1993, 31 (05) : 363 - 368
  • [36] A PHASE-II STUDY OF HIGH-DOSE ESTROGENS (DIETHYLSTILBESTROL DIPHOSPHATE) IN PROSTATE-CANCER
    CITRIN, DL
    KIES, MS
    WALLEMARK, CB
    KHANDEKAR, J
    KAPLAN, E
    CAMACHO, F
    LIND, R
    CANCER, 1985, 56 (03) : 457 - 460
  • [37] PHASE II TRIAL OF 4'-DEOXYDOXORUBICIN (ESORUBICIN) IN HORMONE RESISTANT PROSTATE-CANCER
    BRAICH, T
    AHMANN, FR
    GAREWAL, HS
    ROBERTONE, A
    SALMON, SE
    INVESTIGATIONAL NEW DRUGS, 1986, 4 (02) : 193 - 196
  • [38] PHASE-II STUDY OF SULOFENUR (LY186641) IN MEASURABLE METASTATIC RENAL-CANCER
    WEINERMAN, B
    EISENHAUER, E
    STEWART, D
    MERTENS, W
    TANNOCK, I
    VENNER, P
    SPAULDING, R
    ANNALS OF ONCOLOGY, 1992, 3 (01) : 83 - 84
  • [39] PHASE-II EVALUATION OF MAYTANSINE IN PATIENTS WITH METASTATIC LUNG-CANCER
    EAGAN, RT
    CREAGAN, ET
    INGLE, JN
    FRYTAK, S
    RUBIN, J
    CANCER TREATMENT REPORTS, 1978, 62 (10): : 1577 - 1579
  • [40] PHASE-II EVALUATION OF PALA IN PATIENTS WITH METASTATIC LUNG-CANCER
    CREAGAN, ET
    EAGAN, RT
    FLEMING, TR
    FRYTAK, S
    NICHOLS, WC
    INGLE, JN
    KVOLS, LK
    CANCER TREATMENT REPORTS, 1981, 65 (3-4): : 356 - 357
12345